UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method

Statistical methods in medical research, 2017-04, Vol.26 (2), p.724-751

2017

Volltextzugriff (PDF)

Do Changes in Patellofemoral Joint Offset Lead to Adverse Outcomes in Total Knee Arthroplasty with Patellar Resurfacing? A Radiographic Review

The Journal of arthroplasty, 2017-03, Vol.32 (3), p.783-787.e1

2017

Volltextzugriff (PDF)

Bone marrow micrometastases in early breast cancer-30-year outcome

British journal of cancer, 2016-02, Vol.114 (3), p.243-247

2016

Volltextzugriff (PDF)

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Breast cancer research and treatment, 2014-12, Vol.148 (3), p.581-590

2014

Volltextzugriff (PDF)

The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-12, Vol.29 (12), p.796-798

2017

Volltextzugriff (PDF)

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.169-178

2018

Volltextzugriff (PDF)

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-09, Vol.28 (9), p.e69-e76

2016

Volltextzugriff (PDF)

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Oral oncology, 2014-02, Vol.50 (2), p.141-146

2014

Volltextzugriff (PDF)

Long-term Follow-up of Patients with Early Breast Cancer (EBC) and High Prevalence of Vitamin D Deficiency (VDD)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-06, Vol.29 (6), p.e102-e102

2017

Volltextzugriff (PDF)

1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019)

European journal of cancer (1990), 2015-09, Vol.51, p.S183-S184

2015

Volltextzugriff (PDF)

PO-093: COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients

Radiotherapy and oncology, 2017-03, Vol.122, p.44-45

2017

Volltextzugriff (PDF)

OC-044: ART DECO (CRUK/10/018): dose escalated vs standard dose IMRT in locally advanced head and neck cancer

Radiotherapy and oncology, 2017-03, Vol.122, p.24-24

2017

Volltextzugriff (PDF)

Trains in crosswinds – Comparison of full-scale on-train measurements, physical model tests and CFD calculations

Journal of wind engineering and industrial aerodynamics, 2018-04, Vol.175, p.428-444

2018

Volltextzugriff (PDF)

200 TACT2 Trial in Early Breast Cancer (EBC): Differential Rates of Amenorrhoea in Premenopausal Women Following Adjuvant Epirubicin (E) or Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF (CRUK/05/019)

European journal of cancer (1990), 2012-03, Vol.48, p.S102-S102

2012

Volltextzugriff (PDF)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Volltextzugriff (PDF)

Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD5-05-PD5-05

2018

Volltextzugriff (PDF)

Abstract OT1-06-03: The plasmaMATCH trial: A multiple parallel cohort, open-label, multi-centre phase II clinical trial of ctDNA screening to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-06-03-OT1-06-03

2018

Volltextzugriff (PDF)

A molecular signature predictive of clinical outcome following pazopanib therapy in advanced soft tissue sarcoma

Annals of oncology, 2017-11, Vol.28, p.x149-x149

2017

Volltextzugriff (PDF)

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

BMC medical research methodology, 2011-01, Vol.11 (1), p.4-4, Article 4

2011

Volltextzugriff (PDF)

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study

Statistical methods in medical research, 2018-03, Vol.27 (3), p.765-784

2018

Volltextzugriff (PDF)

Development and validation of multiplex digital PCR assays on circulating tumor DNA in advanced breast cancer: Implementation for clinical routine use

Annals of oncology, 2015-05, Vol.26, p.iii15-iii15

2015

Volltextzugriff (PDF)

Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-01

2017

Volltextzugriff (PDF)

Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-10-02

2017

Volltextzugriff (PDF)

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context: Methods, Limitations, and Recommendations

Medical decision making, 2014-04, Vol.34 (3), p.387-402

2014

Volltextzugriff (PDF)

Abstract P2-09-02: True effect of aromatase inhibitor (AI) treatment on global gene expression (expr) changes in postmenopausal ER+ breast cancer (BC) patients: A POETIC study (CRUK/07/015)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-09-02

2017

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(135)
Life Sciences & Biomedicine
(117)
Humans
(77)
Female
(48)
Biological And Medical Sciences
(43)
Male
(34)
Aged
(32)
Middle Aged
(31)
Fundamental And Applied Biological Sciences. Psychology
(25)
Physical Sciences
(22)
Oncology
(20)
Medical Sciences
(19)
Adult
(18)
Plant Sciences
(16)
Aged, 80 And Over
(15)
Health Care Sciences & Services
(14)
Technology
(14)
General & Internal Medicine
(13)
Hematology, Oncology And Palliative Medicine
(13)
Medicine, General & Internal
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method

Do Changes in Patellofemoral Joint Offset Lead to Adverse Outcomes in Total Knee Arthroplasty with Patellar Resurfacing? A Radiographic Review

Bone marrow micrometastases in early breast cancer-30-year outcome

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Long-term Follow-up of Patients with Early Breast Cancer (EBC) and High Prevalence of Vitamin D Deficiency (VDD)

1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019)

PO-093: COSTAR trial results: 3-D Conformal Radiotherapy vs Cochlea-Sparing IMRT in parotid cancer patients

OC-044: ART DECO (CRUK/10/018): dose escalated vs standard dose IMRT in locally advanced head and neck cancer

Trains in crosswinds – Comparison of full-scale on-train measurements, physical model tests and CFD calculations

200 TACT2 Trial in Early Breast Cancer (EBC): Differential Rates of Amenorrhoea in Premenopausal Women Following Adjuvant Epirubicin (E) or Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF (CRUK/05/019)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study

Abstract OT1-06-03: The plasmaMATCH trial: A multiple parallel cohort, open-label, multi-centre phase II clinical trial of ctDNA screening to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

A molecular signature predictive of clinical outcome following pazopanib therapy in advanced soft tissue sarcoma

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study

Development and validation of multiplex digital PCR assays on circulating tumor DNA in advanced breast cancer: Implementation for clinical routine use

Abstract P2-05-01: Clinico-pathological relationships with Ki67 in POETIC (CRUK/07/015) – Critical lessons for assessing Ki67 for prognosis and as a pharmacodynamic marker

Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context: Methods, Limitations, and Recommendations

Abstract P2-09-02: True effect of aromatase inhibitor (AI) treatment on global gene expression (expr) changes in postmenopausal ER+ breast cancer (BC) patients: A POETIC study (CRUK/07/015)

Suchergebnisse filtern